Josh Levitsky
Overview
Explore the profile of Josh Levitsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
2510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Thuluvath A, Kim M, Peipert J, Duarte-Rojo A, Huang A, Siddiqui O, et al.
Transplant Proc
. 2024 Jul;
56(6):1378-1384.
PMID: 39025730
Introduction: Hepatic encephalopathy (HE) is a frequent complication of cirrhosis, leading to preventable hospitalizations and increased mortality. Despite the availability of validated neuro-psychometric tests to diagnose HE, only 10% of...
12.
Huang C, Su P, Fisher T, Levitsky J, Kelleher N, Forte E
Front Transplant
. 2024 Jul;
2():1286881.
PMID: 38993855
Scarcity of high-quality organs, suboptimal organ quality assessment, unsatisfactory pre-implantation procedures, and poor long-term organ and patient survival are the main challenges currently faced by the solid organ transplant (SOT)...
13.
Husnain A, Malik A, Caicedo J, Nadig S, Borja-Cacho D, Boike J, et al.
Cardiovasc Intervent Radiol
. 2024 Jun;
47(8):1083-1092.
PMID: 38858255
Purpose: This study aimed to present the institutional experience and algorithm for performing biliary interventions in liver transplant patients using the modified Hutson loop access (MHLA) and the impact of...
14.
Przybyszewski E, Wilechansky R, Diaz P, Allegretti A, VanWagner L, Cullaro G, et al.
Liver Transpl
. 2024 Mar;
30(7):753-759.
PMID: 38537069
Hepatorenal syndrome-acute kidney injury (HRS-AKI) is a severe complication of cirrhosis that carries a poor prognosis. The recent Food and Drug Administration approval of terlipressin has substantial implications for managing...
15.
Bellamy C, OLeary J, Adeyi O, Baddour N, Batal I, Bucuvalas J, et al.
Am J Transplant
. 2024 Mar;
24(6):905-917.
PMID: 38461883
The Banff Working Group on Liver Allograft Pathology met in September 2022. Participants included hepatologists, surgeons, pathologists, immunologists, and histocompatibility specialists. Presentations and discussions focused on the evaluation of long-term...
16.
Huang C, Kline J, Negrao F, Robey M, Toby T, Durbin K, et al.
Anal Chem
. 2024 Feb;
96(8):3578-3586.
PMID: 38354049
Existing mass spectrometric assays used for sensitive and specific measurements of target proteins across multiple samples, such as selected/multiple reaction monitoring (SRM/MRM) or parallel reaction monitoring (PRM), are peptide-based methods...
17.
Upadrasta G, Affinati A, Kumar S, Zelada H, Fulkerson C, Gupta S, et al.
Clin Transplant
. 2024 Jan;
38(1):e15239.
PMID: 38289889
Infection and rejection outcomes were retrospectively analyzed in patients following liver transplant and separately following heart transplant with patients being stratified by their severity of immediate postoperative insulin resistance as...
18.
Berenguer M, De Martin E, Hessheimer A, Levitsky J, Maluf D, Mas V, et al.
Transpl Int
. 2023 Sep;
36:11358.
PMID: 37711401
Currently, one-year survival following liver transplantation (LT) exceeds 90% in large international registries, and LT is considered definitive treatment for patients with end-stage liver disease and liver cancer. Recurrence of...
19.
Thuluvath A, Duarte-Rojo A, Lai J, Peipert J, Dietch Z, Siddiqui O, et al.
Transplantation
. 2023 Jul;
108(2):491-497.
PMID: 37496147
Background: Frailty is prevalent in patients with end-stage liver disease and predicts waitlist mortality, posttransplant mortality, and frequency of hospitalizations. The Liver Frailty Index (LFI) is a validated measure of...
20.
Merola J, Emond J, Levitsky J
Transplantation
. 2023 Apr;
107(10):2120-2125.
PMID: 37019173
Biomarkers have the potential to transform the detection, treatment, and outcomes of liver transplant complications, though their application is limited because of the lack of prospective validation. Although many genetic,...